The VASCERN-VASCA Working Group Diagnostic and Management Pathways for Venous Malformations.

Dompmartin, Anne; Baselga, Eulalia; Boon, Laurence M; Diociaiuti, Andrea; Dvorakova, Veronika; El Hachem, May; Gasparella, Paolo; Haxhija, Emir; Ghaffarpour, Nader; Kyrklund, Kristiina; Irvine, Alan D; Kapp, Friedrich G; Rößler, Jochen; Salminen, Päivi; van den Bosch, Caroline; van der Vleuten, Carine; Schultze Kool, Leo; Vikkula, Miikka (2023). The VASCERN-VASCA Working Group Diagnostic and Management Pathways for Venous Malformations. Journal of vascular anomalies, 4(2), e064. Wolters Kluwer Health 10.1097/JOVA.0000000000000064

Preview

Text The_VASCERN_VASCA_Working_Group_Diagnostic_and.1.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (840kB) | Preview

UNLABELLED

To elaborate expert consensus patient pathways to guide patients and physicians toward efficient diagnostics and management of patients with venous malformations.

METHODS

VASCERN-VASCA (https://vascern.eu/) is a European network of multidisciplinary centers for Vascular Anomalies. The Nominal Group Technique was used to establish the pathways. Two facilitators were identified: one to propose initial discussion points and draw the pathways, and another to chair the discussion. A dermatologist (AD) was chosen as first facilitator due to her specific clinical and research experience. The draft was subsequently discussed within VASCERN-VASCA monthly virtual meetings and annual face-to-face meetings.

RESULTS

The Pathway starts from the clinical suspicion of a venous type malformation (VM) and lists the clinical characteristics to look for to support this suspicion. Strategies for subsequent imaging and histopathology are suggested. These aim to inform on the diagnosis and to separate the patients into 4 subtypes: (1) sporadic single VMs or (2) multifocal, (3) familial, multifocal, and (4) combined and/or syndromic VMs. The management of each type is detailed in subsequent pages of the pathway, which are color coded to identify sections on (1) clinical evaluations, (2) investigations, (3) treatments, and (4) associated genes. Actions relevant to all types are marked in separate boxes, including when imaging is recommended. When definite diagnoses have been reached, the pathway also points toward disease-specific additional investigations and recommendations for follow up. Options for management are discussed for each subtype, including conservative and invasive treatments, as well as novel molecular therapies.

CONCLUSION

The collaborative efforts of VASCERN-VASCA, a network of the 9 Expert Centers, has led to a consensus Diagnostic and Management Pathways for VMs to assist clinicians and patients. It also emphasizes the role of multidisciplinary expert centers in the management of VM patients. This pathway will become available on the VASCERN website (http://vascern.eu/).

Interest & Impact

Downloads

3 since deposited on 20 Jun 2023
3 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item